We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.

Delisted

TARO was delisted on the 21st of June, 2024.

159 hedge funds and large institutions have $1.02B invested in Taro Pharmaceutical Industries Ltd. in 2016 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 84 increasing their positions, 33 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

485% more call options, than puts

Call options by funds: $6.99M | Put options by funds: $1.19M

155% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 33

24% more capital invested

Capital invested by funds: $826M → $1.02B (+$199M)

5% less funds holding

Funds holding: 167159 (-8)

16% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 31

38% less funds holding in top 10

Funds holding in top 10: 85 (-3)

Holders
159
Holders Change
-8
Holders Change %
-4.79%
% of All Funds
4.24%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.13%
New
26
Increased
84
Reduced
33
Closed
31
Calls
$6.99M
Puts
$1.19M
Net Calls
+$5.79M
Net Calls Change
+$6.04M
Name Holding Trade Value Shares
Change
Change in
Stake
BA
101
BlackRock Advisors
Delaware
$490K +$235K +1,657 +97%
HSBC Holdings
102
HSBC Holdings
United Kingdom
$482K +$192K +1,355 +69%
COPPSERS
103
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$432K +$201K +1,419 +92%
Credit Agricole
104
Credit Agricole
France
$418K -$270K -1,907 -40%
WAM
105
World Asset Management
Michigan
$411K +$26.9K +190 +7%
Public Sector Pension Investment Board (PSP Investments)
106
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$405K +$394K +2,780 New
JIC
107
Johnson Investment Counsel
Ohio
$402K +$56.7K +400 +17%
Tudor Investment Corp
108
Tudor Investment Corp
Connecticut
$388K +$378K +2,663 New
Zurich Cantonal Bank
109
Zurich Cantonal Bank
Switzerland
$386K +$158K +1,116 +73%
Comerica Bank
110
Comerica Bank
Texas
$384K
EGA
111
Eagle Global Advisors
Texas
$379K
Morgan Stanley
112
Morgan Stanley
New York
$359K -$5.21M -36,726 -94%
PI
113
Putnam Investments
Massachusetts
$349K +$340K +2,398 New
Mitsubishi UFJ Asset Management
114
Mitsubishi UFJ Asset Management
Japan
$320K +$156K +1,100 +100%
BAM
115
Burnham Asset Management
New York
$310K +$302K +2,130 New
ANI
116
American National Insurance
Texas
$302K
Canada Pension Plan Investment Board
117
Canada Pension Plan Investment Board
Ontario, Canada
$291K -$1.13M -8,000 -80%
Commonwealth Equity Services
118
Commonwealth Equity Services
Massachusetts
$289K +$12.3K +87 +5%
RJA
119
Raymond James & Associates
Florida
$278K -$554K -3,907 -67%
Wells Fargo
120
Wells Fargo
California
$274K -$128K -901 -32%
SEI Investments
121
SEI Investments
Pennsylvania
$238K +$24K +169 +12%
PCIG
122
Partners Capital Investment Group
Massachusetts
$237K -$567K -4,000 -71%
PM
123
Parametrica Management
Hong Kong
$233K +$227K +1,600 New
QI
124
QS Investors
New York
$233K +$227K +1,600 New
Citigroup
125
Citigroup
New York
$206K -$162K -1,141 -45%

TARO Hedge Fund Activity: Q2 2016 in Review

159 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q2 2016, worth a combined $1.02B — up 24% from $826M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of TARO and 26 opened new positions — a net loss of 5 holders — while 33 trimmed existing stakes and 84 added.

The largest buyer was Goldman Sachs, adding an estimated $40.6M. The largest seller was Greywolf Capital Management, exiting entirely with an estimated $35.1M sold.

  • 159 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q2 2016, down from 167 in Q1 2016.
  • Funds reported $1.02B of Taro Pharmaceutical Industries Ltd. stock for Q2 2016, up 24% quarter-over-quarter.
  • 26 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q2 2016 and 31 closed out, a net change of -5 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q2 2016 was Goldman Sachs, an estimated $40.6M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q2 2016 was Greywolf Capital Management, an estimated $35.1M sold.

Based on aggregated 13F filings for Q2 2016.